Zealand Pharma's total assets for Q2 2026 were kr19.76B, an increase of 29.15% from the previous quarter. DE:22Z total liabilities were kr1.76B for the fiscal quarter, a 111.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.